Colon Cancer
Showing NaN - NaN of 19
Collection of Blood From Patients With Cancer
Recruiting
- Prostate Cancer
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Where Culture Meets Genetics: Exploring Latinas Causal
Completed
- Colon Cancer
- Breast Cancer
-
Bethesda, MarylandNational Human Genome Research Institute (NHGRI)
Jan 21, 2023
Colon Cancer, Colorectal Cancer, Rectal Cancer Trial in Worldwide (Panitumumab, Bevacizumab, mFOLFOX6)
Subjects Previously Enrolled in Poxviral Vector Gene Transfer
Recruiting
- Prostate Cancer
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 19, 2022
Genomic Services Research Program
Recruiting
- Colon Cancer
- Breast Cancer
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 12, 2022
Mobile Sensor Technologies to Assess General Symptomology of
Enrolling by invitation
- Neoplasms
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 20, 2022
Colon Cancer, Pancreatic Cancer, Cholangiocarcinoma Trial run by the National Cancer Institute (NCI) (MVT-5873, pancreatectomy
Completed
- Colon Cancer
- +4 more
- MVT-5873
- pancreatectomy or hepatectomy
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jun 30, 2022
Tumors, Prostate Cancer, Lung Cancer Trial run by the NCI (ETBX-051; adenoviral brachyury vaccine, ETBX-061; adenoviral Mucin-1
Completed
- Neoplasms
- +4 more
- ETBX-051; adenoviral brachyury vaccine
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 25, 2020
Melanoma, Colon Cancer, Gastrointestinal Cancer Trial run by the NCI (National Cancer Institute (NCI)-4650, a messenger
Terminated
- Melanoma
- +4 more
- National Cancer Institute (NCI)-4650, a messenger ribonucleic acid (mRNA)-based, Personalized Cancer Vaccine
-
Bethesda, MarylandNational Institutes of Health Clinical Center
May 22, 2020
Testing a Spanish Version of a Patient Toxicity Questionnaire
Completed
- Breast Cancer
- +4 more
-
Bethesda, MarylandNational Cancer Institute (NCI), 9000 Rockville Pike
Dec 13, 2019
Breast Cancer, Prostate Cancer, Lung Cancer Trial run by the NCI (111Indium CHX-A)
Terminated
- Breast Cancer
- +3 more
- 111Indium CHX-A
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 8, 2019
Renal Cell Carcinoma, Breast Cancer, Colon Cancer Trial in Bethesda, Hershey, Pittsburgh (DMS 612)
Completed
- Renal Cell Carcinoma
- +4 more
- DMS 612
-
Bethesda, Maryland
- +2 more
Dec 4, 2018
Cancer, Colon Cancer, Colorectal Cancer Trial in Worldwide (Pegfilgrastim, Placebo, Bevacizumab)
Breast Cancer, Colon Cancer, Pancreatic Cancer Trial run by the NCI (p53: 264-272 peptide, CT-011)
Withdrawn
- Breast Cancer
- +4 more
- p53: 264-272 peptide
- CT-011
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017
Colon Cancer, Lung Cancer, Cervical Cancer Trial run by the NCI ((18)Fluciclatide)
Withdrawn
- Colon Cancer
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017
Breast Cancer, Colon Cancer, Bladder Cancer Trial in Bethesda, New York (Glycosylated Recombinant Human Interleukin-7,
Terminated
- Breast Cancer
- +2 more
- Glycosylated Recombinant Human Interleukin-7
- +5 more
-
Bethesda, Maryland
- +1 more
May 16, 2016